It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Adverse events associated with ponatinib in CML and ALL were shown to have decreased significantly since its approval, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Shohreh Aghdashloo has been tapped for a major role in "The Wheel of Time" Season 3. Aghdashloo will play Elaida do Avriny ...

Effect Rally opportunities with undervalued stocks AES Corporation and Actinium Pharmaceuticals. Click for why we are bullish ...

The operator of more than 100 area Arby’s restaurants donated $100,000 to local charities on Thursday. AES Restaurant Group ...

On Thursday, AES Corp (AES) stock saw a decline, ending the day at $13.29 which represents a decrease of $-0.14 or -1.04% from the prior close of $13.43. The stock opened at $13.5 and touched a low of ...

The novel agent soticlestat flopped in a pair of phase III trials for rare seizure disorders, researchers reported here.

LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in ...